160 related articles for article (PubMed ID: 27658833)
1. Antipsychotic treatment, prolactin, and breast tumorigenesis.
De Hert M; Vancampfort D; Stubbs B; Sabbe T; Wildiers H; Detraux J
Psychiatr Danub; 2016 Sep; 28(3):243-254. PubMed ID: 27658833
[TBL] [Abstract][Full Text] [Related]
2. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.
De Hert M; Peuskens J; Sabbe T; Mitchell AJ; Stubbs B; Neven P; Wildiers H; Detraux J
Acta Psychiatr Scand; 2016 Jan; 133(1):5-22. PubMed ID: 26114737
[TBL] [Abstract][Full Text] [Related]
3. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
4. [Prolactin, antipsychotics and breast cancer: is there a connection?].
Sabbe T; Detraux J; De Hert M
Tijdschr Psychiatr; 2016; 58(9):641-9. PubMed ID: 27639886
[TBL] [Abstract][Full Text] [Related]
5. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.
Froes Brandao D; Strasser-Weippl K; Goss PE
Cancer; 2016 Jan; 122(2):184-8. PubMed ID: 26457577
[TBL] [Abstract][Full Text] [Related]
7. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach.
Milano W; Colletti C; Capasso A
Endocr Metab Immune Disord Drug Targets; 2017; 17(1):38-55. PubMed ID: 28440197
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
Roke Y; van Harten PN; Boot AM; Buitelaar JK
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
Poyraz BC; Aksoy C; Balcioğlu I
Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
[TBL] [Abstract][Full Text] [Related]
12. Recent clinical aspects of hyperprolactinemia induced by antipsychotics.
Milano W; D'Acunto CW; De Rosa M; Festa M; Milano L; Petrella C; Capasso A
Rev Recent Clin Trials; 2011 Jan; 6(1):52-63. PubMed ID: 20868350
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole-Associated Hypoprolactinemia in the Clinical Setting.
Sogawa R; Shimomura Y; Minami C; Maruo J; Kunitake Y; Mizoguchi Y; Kawashima T; Monji A; Hara H
J Clin Psychopharmacol; 2016 Aug; 36(4):385-7. PubMed ID: 27281387
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.
Grigg J; Worsley R; Thew C; Gurvich C; Thomas N; Kulkarni J
Psychopharmacology (Berl); 2017 Nov; 234(22):3279-3297. PubMed ID: 28889207
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders.
Takechi K; Yoshioka Y; Kawazoe H; Tanaka M; Takatori S; Kobayashi M; Matsuoka I; Yanagawa H; Zamami Y; Imanishi M; Ishizawa K; Tanaka A; Araki H
Biol Pharm Bull; 2017; 40(10):1775-1778. PubMed ID: 28966250
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Management of Granulomatous Lobular Mastitis Associated with Antipsychotics-Induced Hyperprolactinemia.
Tian C; Wang H; Liu Z; Han X; Ning P
Breastfeed Med; 2022 Jul; 17(7):599-604. PubMed ID: 35447036
[No Abstract] [Full Text] [Related]
17. Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review.
De Hert M; Detraux J; Peuskens J
Expert Opin Drug Saf; 2014 May; 13(5):605-24. PubMed ID: 24697217
[TBL] [Abstract][Full Text] [Related]
18. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
[TBL] [Abstract][Full Text] [Related]
19. Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels.
Ahl J; Kinon BJ; Liu-Seifert H
Ann N Y Acad Sci; 2004 Dec; 1032():289-90. PubMed ID: 15677431
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemia associated with psychotropics--a review.
Madhusoodanan S; Parida S; Jimenez C
Hum Psychopharmacol; 2010; 25(4):281-97. PubMed ID: 20521318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
